Debut Plus

1,722.7

+7.03 +0.41%

17 Jul 2026

NSE Listed · Healthcare

Poly Medicure Limited (POLYMED)

Volume: 90,00052W Range:1,1822,229
Market Cap₹17,482 Cr
Current Price₹1,722.7
Previous Close₹1,715.67
High / Low (52w)₹2,229 / ₹1,182
Volume90,000
Avg Vol (1W)
Avg Vol (1M)
Stock P/E54.28
Book Value₹306.44
Dividend Yield
ROE10.85%
ROA5.75%
Revenue (TTM)
Revenue Growth
Profit Margin
Total Debt
Shares Outstanding
Face Value
EPS (TTM)₹31.74
P/B5.62
Debt / Equity11.23
50 DMA₹1,551.65
200 DMA₹1,606.44
Day change+0.41%
Price Chart
1,722.7 19.16% · 1Y
2423123034.6L
2025-07-17
2026-07-14

20-day avg volume: 1.3L shares

Pros
  • Company is almost debt-free.
  • Revenue grew 12% YoY.
Cons
  • Stock trades at a high P/E of 54.
Quarterly Results
MetricMar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue₹535 Cr₹494 Cr₹444 Cr₹403 Cr₹441 Cr
EBITDA₹130 Cr₹132 Cr₹150 Cr₹149 Cr₹146 Cr
Net Profit₹65 Cr₹71 Cr₹92 Cr₹93 Cr₹92 Cr
EPS6.536.999.069.178.92
Profit & Loss (Annual)
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Revenue₹1,875 Cr₹1,670 Cr₹1,366 Cr₹1,109 Cr
EBITDA₹561 Cr₹548 Cr₹419 Cr₹303 Cr
Net Profit₹331 Cr₹339 Cr₹258 Cr₹179 Cr
EPS34.1126.918.6715.27
Balance Sheet
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Total Assets₹3,919 Cr₹3,192 Cr₹1,859 Cr₹1,577 Cr
Total Liabilities₹769 Cr₹427 Cr₹389 Cr₹336 Cr
Equity₹3,106 Cr₹2,766 Cr₹1,470 Cr₹1,242 Cr
Total Debt₹354 Cr₹180 Cr₹174 Cr₹149 Cr
Cash Flow
MetricMar 2026Mar 2025Mar 2024Mar 2023Mar 2022
Operating₹246 Cr₹233 Cr₹266 Cr₹191 Cr
Investing₹-225 Cr₹-1,187 Cr₹-241 Cr₹-179 Cr
Financing₹20 Cr₹951 Cr₹-20 Cr₹-13 Cr
Free Cash Flow₹-62 Cr₹-98 Cr₹-11 Cr₹-48 Cr
Shareholding
Promoter 65.08% Institutions 17.36% Public 17.56%
About Poly Medicure Limited

Healthcare · Medical Instruments & Supplies

Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally. The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system. It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder. In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products. The company was incorporated in 1995 and is based in New Delhi, India.

www.polymedicure.com
Technical AnalysisPremium

Technical analysis (Premium)

Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.

More stocks

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search